Production review before production spend.
Built with access to a private U.S. manufacturing pathway. Your deposit funds manufacturing review, quote preparation, production intake, and formula and label-readiness review, credited toward production if you are approved to proceed. Manufacturing access is reviewed, not guaranteed.
$5,000
We review your concept and recommend the right step first. No cold checkout.
Manufacturing Path · Readiness Dossier
RestoreRoot Magnesium Glycinate Sleep Gummy · 60-count · Composite Readiness 71/100 (Conditional Go)
What you get: A manufacturer-facing readiness dossier for one SKU: a graded six-dimension scorecard, a corrected formula matrix with overage logic, a defensible-vs-flagged claims ledger, a print-ready label spec, a CMO-readiness brief with RFQ pack, and a 90-day sequenced path to a production-ready handoff.
The $1,997 Brand Validation Sprint tells you whether the concept is worth pursuing; the $5,000 Manufacturing Path hands you the corrected formula matrix, label spec, and CMO/RFQ brief a contract manufacturer can actually quote and run against.
Readiness scorecard · six dimensions (Composite 71/100, Conditional Go)
Formula Strength 74 · magnesium glycinate at a credible per-serving level for a gummy format.
Ingredient Evidence 78 · glycinate is a commonly cited chelate form; citations in the evidence appendix.
Claim Safety 58 (lowest) · draft language drifts toward implied outcome claims; rewrites required before any packaging is printed.
Label Readiness 69 · panel buildable now; two formatting gaps flagged (elemental vs compound weight, allergen line).
Manufacturing Readiness 70 · pectin vs gelatin decision and active-load-per-gummy are the open variables.
Market Fit 76 · defined, crowded shelf; differentiation must come from form quality and claim restraint.
What this reading is · and is not
NutraVeri provides product-readiness intelligence only: a graded view of how prepared this concept is to move toward manufacturing.
This is not medical, regulatory, or legal advice, and is not an FDA review, clearance, or approval of any kind.
Scores reflect readiness signals from the submitted brief; they are not a prediction or guarantee of sales, approval, or compliance outcomes.
'Conditional Go' means: proceed to manufacturer conversations after closing the Claim Safety and Label Readiness corrections in the locked sections.
Corrected formula matrix · per-serving build & overage logic
Claims ledger · defensible vs flagged (line-by-line)
Label spec & CMO / RFQ brief + 90-day path
This is a sample on a demo concept. 2 sections shown in full; the rest unlocks on your own concept.
It is reasonable to be cautious.
Manufacturing is where supplement money gets serious, and where a wrong formula, label, or partner gets expensive fast. NutraVeri is backed by a real FDA-registered, cGMP-aligned manufacturing partner, and partner identity is disclosed only during qualified intake, which keeps the relationship serious and protects both sides. You should know exactly what you are committing to before the capital moves.
The expensive mistake happens before production starts.
A product can look finished and still be unready. These are the places a launch quietly goes wrong. Each one is far cheaper to catch now than after a production run.
Formula feasibility
Whether your formula can actually be produced at dose, format, and cost, before a manufacturer says no.
Label & packaging readiness
Gaps in label structure and packaging intake that stall, or force a re-spin of, a production run.
Claim risk
Where claim language may invite friction with regulators or retailers, with safer-direction notes. Not legal advice.
Manufacturer fit
Matching the concept to an FDA-registered, cGMP-aligned partner that fits your category and MOQ.
Cost & MOQ reality
Whether the unit economics and minimum order quantity match your budget and your goals.
Timeline & sequencing
What has to happen, in what order, before production, so nothing blocks the run.
Production review before production spend.
Your scored concept enters manufacturing review through a private U.S. manufacturing pathway with a real FDA-registered, cGMP-aligned manufacturing partner. NutraVeri helps founders prepare for the manufacturing conversation before money moves: we prepare a quote path, run label and packaging intake, and return a clear recommendation (go, refine, or pause). Production-readiness depends on formula, label, claims, MOQ, packaging, and partner approval. Manufacturing access is reviewed, not guaranteed.
- 1
Intake
Share your scored concept, formula, label, and packaging direction through a secure intake.
- 2
Review & quote
Feasibility review, manufacturer-readiness check, and quote preparation with transparent pricing.
- 3
Go / refine / pause
A clear recommendation and a prioritized risk/fix list, credited toward production if approved to proceed.
- Production intake
- Formula feasibility review
- Packaging and label-readiness review
- Quote-path preparation
- Manufacturer-readiness review
- Production timeline estimate
- Risk and fix list before production
- Preparation for the manufacturing conversation before money moves
- Deposit credited toward production if approved
- A clear go / refine / pause recommendation
A go, refine, or pause recommendation, with the work behind it.
Your deposit funds the preparation a serious manufacturing conversation requires, returned as a clear recommendation and a prioritized list.
A feasibility read on whether your formula can be produced at dose, format, and cost.
A label and packaging intake review, so the expensive mistakes get caught on paper.
A quote-path preparation and manufacturer-readiness check against an FDA-registered, cGMP-aligned partner.
A prioritized risk and fix list, and a clear go, refine, or pause recommendation. Deposit credited toward production if approved.
“We would rather stop a weak product than manufacture the wrong one.”
You are eligible once you have a scored concept. After payment, your concept enters manufacturing review, and we prepare your quote path, label and packaging intake, and a go / refine / pause recommendation. If approved to proceed, your deposit is credited toward production. If your concept is not ready, you receive the readiness findings instead of being pushed into manufacturing too early. What is not promised: manufacturing access is reviewed, not guaranteed, and there is no guaranteed acceptance or approval. Production-readiness depends on formula, label, claims, MOQ, packaging, and partner approval. Final deposit terms, refund and credit policy, and delivery details are provided before checkout.
Not every formula should move into production, and manufacturing access is reviewed, not guaranteed. That is the point. NutraVeri helps founders prepare for the manufacturing conversation before money moves, identifying what is ready, what needs refinement, and what should pause before larger capital is committed.
We review your concept and recommend the right step first. No cold checkout.
Founders with a scored concept ready to move toward production
Brands preparing a manufacturing run who want a feasibility and quote path first
Teams who want a go / refine / pause call before committing capital
Concepts that have not been built and scored yet. Start free, then come back
Anyone seeking an FDA approval, certification, or compliance ruling. This is readiness review, not approval
- 1
You land on a Manufacturing Path prep page with your intake steps.
- 2
A receipt and a what-to-prepare email arrive in your inbox.
- 3
Your Product Lab updates to show the Manufacturing Path review has started, with the order under Orders and Receipts.
- 4
You submit your scored concept, formula, label, and packaging direction through a secure intake.
- 5
Partner review begins. You receive a go, refine, or pause recommendation. Manufacturing access is reviewed, not guaranteed.
Partner identity is disclosed only during qualified intake. Questions any time: corporate@nutraveri.com.
Your score, reports, Passport, review status, receipts, and next steps live in one private Product Lab. Open it any time, or sign in with the same email you used at checkout to reconnect.
Your formula stays yours.
Does the deposit guarantee I can manufacture?
No. Manufacturing access is reviewed, not guaranteed. The deposit funds production review, quote preparation, and label and packaging intake. If approved to proceed, the deposit is credited toward production.
Who is the manufacturing partner?
A private U.S.-based, FDA-registered, cGMP-aligned manufacturing partner. Partner identity is disclosed only during qualified intake, which keeps the relationship serious and protects both sides.
Is this FDA approval or a compliance ruling?
No. This is product-readiness review, not approval. Products are not FDA-approved, and this is not legal, medical, or regulatory advice.
What happens right after I pay?
You land on a prep page, receive a receipt and a what-to-prepare email, and your Product Lab updates to show the review has started.
Is the deposit refundable or creditable?
If approved to proceed, the deposit is credited toward production. Final deposit, refund, and credit terms are provided before checkout.
Can I access everything later?
Yes. Your intake status, recommendation, and receipt live in your Product Lab. Sign in with the same email you used at checkout.
Can I share this with a partner or investor?
Yes. You can forward this page, which shares public information only. Your formula and intake are never shared unless you choose to share them.
What if my concept is not ready?
You receive the readiness findings instead of being pushed into manufacturing too early. That is the point of reviewing before production spend.
Reviewing this with a co-packer, consultant, partner, or investor? Send them the page. It shares public information only, never your formula.
Manufacturing access is reviewed, not guaranteed, and is subject to qualification, partner availability, review, pricing, and production feasibility. Partner identity is disclosed only during qualified intake. Production-readiness depends on formula, label, claims, MOQ, packaging, and partner approval. Products are not FDA-approved. This is informational product-readiness intelligence, not legal, medical, or regulatory advice.
